当前位置:首页 - 行情中心 - 共同药业(300966) - 财务分析 - 资产负债表

共同药业

(300966)

  

流通市值:14.06亿  总市值:21.58亿
流通股本:7513.22万   总股本:1.15亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金130,486,537.6304,299,912.31116,793,029.53181,973,811.45
应收票据及应收账款202,188,554.48212,699,394.34218,626,088.17219,701,890.69
其中:应收票据21,645,710.6216,020,652.526,250,022.239,502,405.17
应收账款180,542,843.86196,678,741.82212,376,065.94210,199,485.52
应收款项融资7,829,570.5816,624,976.979,205,533.6415,694,632.58
预付款项21,848,248.5722,486,158.2228,118,132.6519,796,737
其他应收款合计2,849,325.932,526,389.922,493,662.882,146,241.55
存货383,824,667.7389,561,155.94370,732,972.76396,157,512.81
其他流动资产9,294,465.2335,189,348.726,731,260.3234,259,728.97
流动资产平衡项目0000
流动资产合计758,322,380.59983,388,346.9772,701,690.45869,731,565.5
非流动资产:
长期股权投资48,553,666.1448,489,605.5448,121,851.0248,235,950.28
投资性房地产18,172,062.6518,329,572.4618,487,082.2718,644,592.08
固定资产858,214,432.4517,696,778.25203,319,754.02208,991,308.72
在建工程856,414,467.391,056,597,331.031,320,133,111.811,181,676,130.86
使用权资产85,051.9399,227.261,091,565.251,208,691.1
无形资产50,159,672.2450,438,278.5250,716,884.850,995,491.08
长期待摊费用10,211,801.2211,295,204.5111,838,136.9812,651,304.86
递延所得税资产33,834,680.9428,404,434.3923,546,956.822,621,685.38
其他非流动资产63,284,979.5257,735,036.4528,622,344.9332,983,979.32
非流动资产平衡项目0000
非流动资产合计1,938,930,814.431,789,085,468.411,705,877,687.881,578,009,133.68
资产平衡项目0000
资产总计2,697,253,195.022,772,473,815.312,478,579,378.332,447,740,699.18
流动负债:
短期借款252,273,011.1236,267,427.78177,163,151.38110,092,522.22
应付票据及应付账款477,989,551.83510,116,706.26501,949,451.78532,236,731.62
其中:应付票据71,474,971.0489,368,286.02124,414,360.5216,813,793.21
应付账款406,514,580.79420,748,420.24377,535,091.28315,422,938.41
预收款项212,697.27354,495.42496,293.5845,292.31
合同负债1,192,191.8806,793.581,142,837.513,468,912.29
应付职工薪酬5,253,938.754,694,463.575,319,755.387,403,890.55
应交税费2,838,439.77874,849.52,096,409.884,084,373.32
其他应付款合计796,833.2700,375.33633,706.461,640,492.53
一年内到期的非流动负债21,444,124.3925,931,392.3820,334,524.9522,723,181.05
其他流动负债20,000,302.0129,132,804.432,989,412.094,710,546.89
流动负债平衡项目0000
流动负债合计782,001,090.12808,879,308.25712,125,543.01686,405,942.78
非流动负债:
长期借款420,963,408.74502,078,507.11334,115,867.85349,715,867.85
应付债券321,446,330.06315,135,143.87308,900,713.25302,658,126.92
租赁负债00451,444.51538,628.82
预计负债030,002.530,002.530,002.5
递延收益141,389,053.67105,495,25195,500,819.4284,327,123.79
递延所得税负债12,759.3614,884.09257,296.18289,416.56
非流动负债平衡项目0000
非流动负债合计883,811,551.83922,753,788.57739,256,143.71737,559,166.44
负债平衡项目0000
负债合计1,665,812,641.951,731,633,096.821,451,381,686.721,423,965,109.22
所有者权益(或股东权益):
实收资本(或股本)115,279,306115,279,306115,278,902115,278,902
其他权益工具96,490,723.0996,490,723.0996,493,567.4496,493,567.44
资本公积412,259,985.75412,019,125.25411,303,748.06410,774,731.48
盈余公积9,861,298.499,861,298.499,861,298.499,861,298.49
未分配利润304,336,230.59313,379,855.2323,888,332.79320,341,025.75
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计938,227,543.92947,030,308.03956,825,848.78952,749,525.16
少数股东权益93,213,009.1593,810,410.4670,371,842.8371,026,064.8
股东权益平衡项目0000
股东权益合计1,031,440,553.071,040,840,718.491,027,197,691.611,023,775,589.96
负债和股东权益合计2,697,253,195.022,772,473,815.312,478,579,378.332,447,740,699.18
公告日期2024-10-242024-08-282024-04-262024-04-26
审计意见(境内)标准无保留意见
TOP↑